This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Infex Therapeutics Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations by Fredrik Wångsell
Introduction
Fredrik Wångsell is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of antibacterial compounds, holding two patents that focus on innovative methods for treating bacterial infections.
Latest Patents
Wångsell's latest patents involve compounds of formula (I) that serve as enzyme inhibitors, specifically targeting metallo-β-lactamase. These compounds can be used in conjunction with antibacterial agents, particularly carbapenems, to effectively treat bacterial infections. The inventions highlight the potential for new treatment options in combating antibiotic resistance.
Career Highlights
Fredrik Wångsell is associated with Infex Therapeutics Limited, where he continues to advance research in antibacterial therapies. His work is pivotal in developing novel compounds that can enhance the efficacy of existing antibacterial treatments.
Collaborations
Wångsell collaborates with esteemed colleagues such as Ian Cooper and David Orr, contributing to a dynamic research environment focused on innovative solutions in healthcare.
Conclusion
Fredrik Wångsell's contributions to antibacterial compounds represent a significant advancement in medical science. His innovative work continues to pave the way for new treatments in the fight against bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile